Benzenesulfonamides
![eMolecules 127-56-0 | Sulfacetamide sodium | Combi-Blocks, Inc. | MFCD00007885 | 236.220 | C8H9N2NaO3S | 98.000 | [Na+].CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1 | 25g | 603132938](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502185650.JPG-250.jpg)
eMolecules 127-56-0 | Sulfacetamide sodium | Combi-Blocks, Inc. | MFCD00007885 | 236.220 | C8H9N2NaO3S | 98.000 | [Na+].CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1 | 25g | 603132938
Sulfacetamide sodium | Combi-Blocks, Inc. | 127-56-0 | MFCD00007885 | 236.220 | C8H9N2NaO3S | 98.000 | [Na+].CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1 | 25g | 603132938
eMolecules 773-64-8 | 2-Mesitylenesulfonyl chloride | Ambeed | MFCD00007434 | 218.700 | C9H11ClO2S | 95.000 | Cc1cc(C)c(c(C)c1)S(Cl)(=O)=O | 25g | 552746994
2-Mesitylenesulfonyl chloride | Ambeed | 773-64-8 | MFCD00007434 | 218.700 | C9H11ClO2S | 95.000 | Cc1cc(C)c(c(C)c1)S(Cl)(=O)=O | 25g | 552746994
Sigma Aldrich Fine Chemicals Biosciences Sulpiride impurity A European Pharmacopoeia (EP) Reference Standard | 26116-12-1 | MFCD00003178 |
Sulpiride impurity A European Pharmacopoeia (EP) Reference Standard | Mol Wt: 128.22 | 26116-12-1 | MFCD00003178 |
Enzo Life Sciences BRL-50481 (10mg). CAS: 433695-36-4
The first selective PDE7 inhibitor (Ki=180 nM). Formulation: Lyophilized. Purity: ≥98% (HPLC). Long Term Storage: Ambient.
Sigma Aldrich Fine Chemicals Biosciences Tolbutamide United States Pharmacopeia (USP) Reference Standard | 64-77-7 | MFCD00027169 | 200MG
Tolbutamide United States Pharmacopeia (USP) Reference Standard | Mol Wt: 270.35 | 64-77-7 | MFCD00027169 | 200MG
Strem, An Ascensus Company CAS# 144222-34-4. 2g. (1R,2R)-(-)-N-(4-toluenesulfonyl)-1,2-diphenylethylenediamine, 98% (R,R)-TsDPEN. MFCD02093428
CAS# 144222-34-4. 2g. (1R,2R)-(-)-N-(4-toluenesulfonyl)-1,2-diphenylethylenediamine, 98% (R,R)-TsDPEN. MFCD02093428. Molecular Weight: 366.48. Molecular Formula: C21H22N2O2S. Color/form: white xtl. Strem# 07-2371. http://www.strem.com/catalog/v/07-2371/
Enzo Life Sciences BRL-50481 (50mg). CAS: 433695-36-4
The first selective PDE7 inhibitor (Ki=180 nM). Formulation: Lyophilized. Purity: ≥98% (HPLC). Long Term Storage: Ambient.
Medchemexpress LLC Seclidemstat mesylate | 2044953-70-8 | 99.8% | 547.04 g·mol⁻¹ | C21H27ClN4O7S2 | 10 MG
Seclidemstat mesylate is a research-grade, reversible, noncompetitive inhibitor of lysine-specific demethylase 1 (KDM1A/LSD1) used in preclinical studies. It demonstrates potent biochemical activity and is applied in oncology and virology research, including investigations of SWI/SNF-complex-mutated tumors and fusion-positive sarcomas.
- Reversible, noncompetitive KDM1A (LSD1) inhibitor suitable for biochemical and cell-based assays.
- Demonstrated potency with Ki = 31 nM and IC50 = 13 nM.
- High-purity solid form for reliable experimental reproducibility.
- Available in multiple packaging sizes, including small research quantities.
- Stable when stored under recommended conditions for both short- and long-term use.
![Medchemexpress LLC 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide | 287403-39-8 | 99.6% | 398.50 g/mol | C17H22N2O5S2 | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000245422.png-250.jpg)
Medchemexpress LLC 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide | 287403-39-8 | 99.6% | 398.50 g/mol | C17H22N2O5S2 | 50 MG
TMI-1 (WAY-171318) is a small-molecule research tool that potently inhibits TNF-α converting enzyme (TACE/ADAM17) and multiple matrix metalloproteinases, induces apoptosis via caspase-dependent pathways, and has demonstrated activity in cell-based assays and animal models of inflammation and cancer.
- Potent TACE inhibition (reported IC50 ≈ 8.4 nM)
- Induces apoptosis in cancer cell lines via caspase-dependent mechanisms
- Reduces TNF-α secretion and alleviates inflammatory symptoms in animal models
- Available as solid and solution forms for in vitro and in vivo use
- High purity suitable for research applications
eMolecules 913835-57-1 | N-(2-Hydroxyethyl) 3-boronobenzenesulfonamide | Combi-Blocks | MFCD08436067 | 245.060 | C8H12BNO5S | 97.000 | OCCNS(=O)(=O)c1cccc(c1)B(O)O | 1g | 117522751
N-(2-Hydroxyethyl) 3-boronobenzenesulfonamide | Combi-Blocks | 913835-57-1 | MFCD08436067 | 245.060 | C8H12BNO5S | 97.000 | OCCNS(=O)(=O)c1cccc(c1)B(O)O | 1g | 117522751